← All Sponsors
SPONSOR

PETHEMA Foundation

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Relapsed Multiple Myeloma
NCT05060627 Phase 1, Phase 2
Recruiting

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Relapsed Multiple Myeloma
Spain View Trial →